Search company, investor...

Founded Year



Series B | Alive

Total Raised


Last Raised

$4.5M | 12 yrs ago

About XCyton

Xcyton provides medical diagnosis for critical care infections. It offers a wide array of immunodiagnostic and molecular diagnostic services, clinical tests, and diagnostic facilities. The company was founded in 1993 and is based in Bangalore, India.

Headquarters Location

No.449, 10th Cross, 4th Phase Peenya Industrial Area

Bangalore, 560 058,




Latest XCyton News

XCyton Diagnostics Ltd Medical Equipment Deals and Alliances Profile Report Updated 22122017 Prices from USD $250

Jan 2, 2018

16:23 EST 2 Jan 2018 | BioPortfolio Reports Summary XCyton Diagnostics Ltd Xcyton is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection ; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It provides molecular diagnostic services in the areas of eye infections, brain infections and blood stream infections. The company offers tests on CNS infections, blood stream infections, infections on immunosuppressed, ophthalmic infections, and preventive diagnosis. Xcyton is headquartered in Bangalore, Karnataka, India. XCyton Diagnostics Ltd Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

XCyton Frequently Asked Questions (FAQ)

  • When was XCyton founded?

    XCyton was founded in 1993.

  • Where is XCyton's headquarters?

    XCyton's headquarters is located at No.449, 10th Cross, 4th Phase, Bangalore.

  • What is XCyton's latest funding round?

    XCyton's latest funding round is Series B.

  • How much did XCyton raise?

    XCyton raised a total of $4.5M.

  • Who are the investors of XCyton?

    Investors of XCyton include F-Prime Capital, Eight Roads Ventures, Birthstone Capital Advisors and Amvar Ventures.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.